Manufacturers Life Insurance Company, The Eloxx Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$1.56 - $3.65 $27,811 - $65,072	-17,828 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.96 - $7.96 $3,175 - $12,895	1,620 Added 10.0%	17,828 $35,000
Q4 2019 Feb 14, 2020	SELL	$3.19 - $7.56 $3,550 - $8,414	-1,113 Reduced 6.43%	16,208 $119,000
Q3 2019 Nov 12, 2019	BUY	$4.37 - $9.91 $5,930 - $13,447	1,357 Added 8.5%	17,321 $78,000
Q2 2019 Aug 14, 2019	BUY	$8.77 - $12.49 $140,004 - $199,390	15,964 New	15,964 $159,000
Q3 2018 Nov 14, 2018	SELL	$11.95 - $19.63 $197,641 - $324,660	-16,539 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$8.75 - $23.27 $144,716 - $384,862	16,539 New	16,539 $282,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.